Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Mahzi Therapeutics Inc.

Mahzi Therapeutics Inc.

Stage unknownSouth San Francisco, CAmahzi.comBiotechnology

Mahzi aims to unite patient and family groups, academic researchers, other industry members, and our internal team of experts to develop therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders. Our team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases.

Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
6
Financing history
1 rounds
  1. Oct 7, 2021
    Form D equity offering · $52.6M (form d sold) · 11 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Mahzi Therapeutics Inc. filed Form D/A: $52,586,424 sold of $52,586,424, Biotechnology”
Investors on record
7 edges
People
1 officers, 4 directors
Timeline
1
  1. Jul 8, 2024
    Mahzi Therapeutics Inc. filed Form D/A: $52,586,424 sold of $52,586,424, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company